<DOC>
	<DOC>NCT00060931</DOC>
	<brief_summary>Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure</brief_summary>
	<brief_title>Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Inclusion criteria: Patients at screening must be insulin producing Type II diabetics (C peptide positive). Patients must have a history of mild to moderate hypertension (140179 systolic blood pressure; 9019 diastolic blood pressure) Patients must be on a stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments. Patients must be on stable antidiabetic regimen (drug treated or diet alone). Patient''s laboratory result for HbA1c must be 6.5 8.5 (drug treated) or 6.5 7.5 (diet alone). Exclusion criteria: Patients using betablocker therapy.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>hypertension</keyword>
	<keyword>beta-blockers</keyword>
	<keyword>Type 2 diabetes</keyword>
</DOC>